Forrest Hu | General Manager of International Business
3SBio Inc | China

Forrest Hu, General Manager of International Business, 3SBio Inc

Mr HU is working for 3S Pharmaceutical Group, which includes the main subsidiaries such as Shanghai CP Guojian, Shengyan SunShine, Zhejiang Wangshen, Shenzheng Sciprogen and Italy Sirton. Mr HU is the General Manager of International Business Unit of the Group. Mr HU is in charge of the International Sales, Business Development, Global Strategic Cooperation, as well as Regulatory Affairs, etc. MR HU has many years' experience in fields of like quality, production, R&D, international business, as well as BD affairs (license in & out). 3S Pharma is one of the largest listed pharmaceutical companies in Hong Kong stock market(01530.HK), with the main marketing products like: Etanercept(launched in 10 countries), Daclizumab, EPO(launched in 22 countries), TPO(launched in 5 countries), Interferon-Alpha, etc. 


Phar-East Day One @ 11:20

Invention vs innovation: How Asian pharma companies remain competitive in the biosimilar space

Asian companies have seen more success in the generics and biosimilars space compared to their peers in developed markets. With the success of Celltrion, Samsung, Dr Reddy’s, Biocon and more Asian pharma companies, should Asian companies focus on core expertise to improvise originator drugs, or on inventing new drugs for Asia-specific diseases?

back to speakers